Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1CNS 1

Conditions

Thrombocytopenia 1Lymphoma 1Intraocular Lymphoma 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1

Interventions

eltrombopag 3Etoposide 3Cytarabine 3romiplostim 2Platelet Transfusion 2Lenalidomide 2Filgrastim 2Cyclosporine 2Cyclophosphamide 2sodium thiosulfate 1siltuximab 1pegfilgrastim 1ofatumumab 1fludarabine phosphate 1etoposide phosphate 1avatrombopag 1alvocidib 1Vorinostat 1Vitamin E 1Vincristine 1Topotecan 1Thioguanine 1Surveys and Questionnaires 1Rituximab 1Ritonavir 1Radiotherapy 1Quality of Life 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × sodium thiosulfate × Lymphoid × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡